Topchoice Medical Corp. Hits Day High with Strong Intraday Performance

Topchoice Medical Corp. has experienced a notable increase of 4.64% on February 24, 2026, reaching an intraday high of CNY 50.30. This performance stands in contrast to the China Shanghai Composite, which declined by 1.26% on the same day. Over the past week, Topchoice Medical Corp. has shown a modest gain of 0.62%, while its one-month performance reflects a significant increase of 17.77%. Despite these short-term gains, the company has faced challenges over the longer term, with a three-year performance decline of 68.32% and a five-year drop of 81.94%. However, recent financial metrics indicate some positive developments, including a decrease in raw material costs by 0.47% year-over-year and a low debt-equity ratio of 17.06%. Topchoice Medical Corp. reported net sales of CNY 841.77 million in the latest quarter, marking a peak for the company. With a market capitalization of CNY 15,054 million, the company maintains a return on equity of 14.06% and a price-to-book ratio of 4.73, reflecting its current valuation in the hospital industry.